James Peyer, Director, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 2,500 shares at $3.65 ($9K) on 2022-02-25, disclosed to the SEC on 2022-02-28.
Open-market purchase of $9k SNSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |